GH

Guardant Health, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$154.86

Price (1 Year)

$179.38 $78.6

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %19.1 / %30
Non-compliant assets / Total market cap %13.1 / %30
Non-compliant revenue / Total income %3 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect cancer at the molecular level; and Guardant360 Tissue test, a molecular profiling test for tumor tissue that provides genomic, transcriptomic, and epigenomic insights.

Website

Analysis (Turkish): GH Hissesi Caiz mi, Helal mi? Guardant Health, Inc. Katılım Analizi